NewEdge Wealth’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Sell
2,271
-71
-3% -$14.8K 0.01% 837
2026
Q1
$495K Sell
2,342
-1,012
-30% -$218K 0.01% 819
2025
Q4
$689K Buy
3,354
+1,090
+48% +$205K 0.01% 733
2025
Q3
$446K Buy
2,264
+111
+5% +$17.1K 0.01% 787
2025
Q2
$330K Sell
2,153
-19
-0.9% -$2.82K 0.01% 805
2025
Q1
$299K Buy
2,172
+345
+19% +$44K 0.01% 773
2024
Q4
$216K Buy
+1,827
New +$213K ﹤0.01% 869

Other funds holding CAH

NewEdge Wealth's CAH Position: Q2 2026 in Review

NewEdge Wealth reduced its Cardinal Health (CAH) stake by 3% in Q2 2026, selling an estimated $14.8K and leaving 2,271 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #837.

NewEdge Wealth first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $689K in Q4 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • NewEdge Wealth held 2,271 shares of Cardinal Health worth $539K as of Q2 2026.
  • NewEdge Wealth sold 71 Cardinal Health shares in Q2 2026, an estimated $14.8K.
  • Cardinal Health made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #837 holding.
  • NewEdge Wealth first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • NewEdge Wealth's Cardinal Health position peaked at $689K in Q4 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.